GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging

Biochemical and Biophysical Research Communications

Volumn 389, Issue 3, 2009, Pages 523-526

  Mukai, Eri ^a,b   Toyoda, Kentaro ^a   Kimura, Hiroyuki ^a   Kawashima, Hidekazu ^a   Fujimoto, Hiroyuki ^a,b   Ueda, Masashi ^c   Temma, Takashi ^a   Hirao, Konomu ^d   Nagakawa, Kenji ^d   Saji, Hideo ^a   Inagaki, Nobuya ^a,e  

^a KYOTO UNIVERSITY   (Japan)

^b Japan Association for the Advancement of Medical Equipment   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d ARKRAY Healthcare Pvt Ltd   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Diabetes; Exendin(9 39); Exendin 4; Glucagon like peptide 1; Glucagon like peptide 1 receptor; Islet imaging; Molecular imaging; Cell imaging; Cell mass

Indexed keywords

BOLTON HUNTER REAGENT I 125; EXENDIN(9 39); GLUCAGON LIKE PEPTIDE 1 RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; EXENDIN (9 39); EXENDIN (9-39); GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; GREEN FLUORESCENT PROTEIN; PEPTIDE FRAGMENT; RADIOACTIVE IODINE;

ANIMAL CELL; ARTICLE; CLINICAL EVALUATION; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOACTIVITY; ANIMAL; DRUG ANTAGONISM; GENETICS; METABOLISM; MOLECULAR PROBE; SCINTISCANNING; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; GREEN FLUORESCENT PROTEINS; INSULIN-SECRETING CELLS; IODINE RADIOISOTOPES; MALE; MICE; MICE, TRANSGENIC; MOLECULAR PROBES; PEPTIDE FRAGMENTS; RECEPTORS, GLUCAGON;

EID: 70449718865     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.014     Document Type: Article

References (18)

1. W.V. Tamborlane, W. Bonfig, E. Boland, Recent advances in treatment of youth with type 1 diabetes: better care through technology, Diabet. Med. 18 (2001) 864-870.
2. L. Groop, Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion, Int. J. Clin. Pract. Suppl. (2000) 3-13.
3. H. Sakuraba, H. Mizukami, N. Yagihashi, R. Wada, C. Hanyu, S. Yagihashi, Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients, Diabetologia 45 (2002) 85-96.
4. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, P.C. Butler, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes 52 (2003) 102-110.
5. K.H. Yoon, S.H. Ko, J.H. Cho, J.M. Lee, Y.B. Ahn, K.H. Song, S.J. Yoo, M.I. Kang, B.Y. Cha, K.W. Lee, H.Y. Son, S.K. Kang, H.S. Kim, I.K. Lee, S. Bonner-Weir, Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea, J. Clin. Endocrinol. Metab. 88 (2003) 2300-2308.
6. J. Rahier, Y. Guiot, R.M. Goebbels, C. Sempoux, J.C. Henquin, Pancreatic beta-cell mass in European subjects with type 2 diabetes, Diabetes Obes. Metab. 10 (Suppl. 4) (2008) 32-42.
7. S. Schneider, Efforts to develop methods for in vivo evaluation of the native beta-cell mass, Diabetes Obes. Metab. 10 (Suppl. 4) (2008) 109-118.
8. L.L. Baggio, D.J. Drucker, Biology of incretins: GLP-1 and GIP, Gastroenterology 132 (2007) 2131-2157.
9. J.J. Holst, The physiology of glucagon-like peptide 1, Physiol. Rev. 87 (2007) 1409-1439.
10. J. Eng, W.A. Kleinman, L. Singh, G. Singh, J.P. Raufman, Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas, J. Biol. Chem. 267 (1992) 7402-7405.
11. R. Goke, H.C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, B. Goke, Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells, J. Biol. Chem. 268 (1993) 19650-19655.
12. M. Hara, X. Wang, T. Kawamura, V.P. Bindokas, R.F. Dizon, S.Y. Alcoser, M.A. Magnuson, G.I. Bell, Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells, Am. J. Physiol. Endocrinol. Metab. 284 (2003) E177-E183.
13. + channel block by sulfonylurea in pancreatic beta-cells, Am. J. Physiol. 274 (1998) E38-E44.
14. R. Sutton, M. Peters, P. McShane, D.W. Gray, P.J. Morris, Isolation of rat pancreatic islets by ductal injection of collagenase, Transplantation 42 (1986) 689-691.
15. S. Al-Sabah, D. Donnelly, A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors, Br. J. Pharmacol. 140 (2003) 339-346.
16. M. Gotthardt, G. Lalyko, J. van Eerd-Vismale, B. Keil, T. Schurrat, M. Hower, P. Laverman, T.M. Behr, O.C. Boerman, B. Goke, M. Behe, A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents, Regul. Pept. 137 (2006) 162-167.
17. S.E. Kahn, D.B. Carr, M.V. Faulenbach, K.M. Utzschneider, An examination of beta-cell function measures and their potential use for estimating beta-cell mass, Diabetes Obes. Metab. 10 (Suppl. 4) (2008) 63-76.
18. M. Schottelius, H.J. Wester, Molecular imaging targeting peptide receptors, Methods 48 (2009) 161-177.